Nitric Oxide Agreement Signed
July 24, 2011
Posted by chcablogadmin in : CHCA News, Cost Reduction, Group Purchasing
Over the last several months, CHCA has been working with Owner Hospitals to reduce your spend on nitric oxide, a patent protected drug which costs CHCA Owners nearly $70 million per year. Guided by the work of an Owner Hospital Task Force, a Nitric Oxide Services Agreement has been signed with Ikaria (INOtherapy) to provide platinum-tier pricing (unlimited utilization) for a period of five years. The potential savings for Owner Hospitals is $3.6 million annually.
Letters of Commitment were sent to each Owner Hospital supply chain management director. Owners will have 90 days (from contract effective date of June 30, 2011) to return the LOC. If you have questions about your hospital’s opportunity specifics, please contact your supply chain leader or Sean Jeffries (sean.jeffries@chca.com).
Comments»
no comments yet - be the first?